✦ LIBER ✦

Treatment of fibrosing cholestatic hepatitis with lamivudine

✍ Scribed by Tak–Mao Chan*; Pui–Chee Wu‡; Fu–Keung Li*; Ching–Lung Lai*; Ignatius K.P. Cheng*; Kar–Neng Lai*

Book ID: 118520333
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 551 KB
Volume: 115
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(98)70380-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fibrosing cholestatic hepatitis C unasso

Fibrosing cholestatic hepatitis C unassociated with transplantation

✍ Daniel Gelrud; Frank Nelson; Tanaka Kathrin; Miriam Pinon; Lawrence J. Brandt 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 28 KB

Successful Treatment of Fibrosing Choles

Successful Treatment of Fibrosing Cholestatic Hepatitis After Liver Transplantation

✍ B. Cimsit; D. Assis; C. Caldwell; A. Arvelakis; T. Taddei; S. Kulkarni; M. Schil 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Fibrosing cholestatic hepatitis in patie

Fibrosing cholestatic hepatitis in patient with HIV and hepatitis B

✍ JaneW.S. Fang; TeresaL. Wright; JohnsonY.N. Lau 📂 Article 📅 1993 🏛 The Lancet 🌐 English ⚖ 170 KB

Lamivudine transiently reduces viral loa

Lamivudine transiently reduces viral load and improves liver function in liver transplant recipients with fibrosing cholestatic hepatitis

✍ Hans L. Tillmann; Christian Trautwein; C.Thomas Bock; Isabella Glomb; Martin Krü 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 39 KB

Fibrosing cholestatic hepatitis in renal

Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection

✍ Delladetsima, Johanna K. ;Boletis, John N. ;Makris, Fotis ;Psichogiou, Mina ;Kos 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 445 KB

Fibrosing cholestatic hepatitis (FCH) has been described as a specific manifestation of hepatitis B virus (HBV) infection in liver allograft recipients characterized by a rapid progression to liver failure. Only sporadic cases have been reported in other immunocompromised groups infected with HBV an

489 ANTIVIRAL TREATMENT IMPROVES SURVIVA

489 ANTIVIRAL TREATMENT IMPROVES SURVIVAL OF PATIENTS WITH CHOLESTATIC FIBROSING HEPATITIS AFTER LIVER TRANSPLANTATION FOR HEPATITIS C

✍ G. Robaeys; D. Cassiman; D. Monbaliu; R. Aerts; J. Pirenne; F. Nevens 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 66 KB